Skip to main content
Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.32
-0.35 (-3.57%)
Feb 21, 2025, 4:00 PM EST - Market closed

Theravance Biopharma Revenue

Theravance Biopharma had revenue of $16.87M in the quarter ending September 30, 2024, with 7.49% growth. This brings the company's revenue in the last twelve months to $63.19M, up 15.93% year-over-year. In the year 2023, Theravance Biopharma had annual revenue of $57.42M with 11.84% growth.

Revenue (ttm)
$63.19M
Revenue Growth
+15.93%
P/S Ratio
7.20
Revenue / Employee
$638,303
Employees
99
Market Cap
458.06M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202357.42M6.08M11.84%
Dec 31, 202251.35M-3.97M-7.17%
Dec 31, 202155.31M-16.55M-23.03%
Dec 31, 202071.86M-1.56M-2.12%
Dec 31, 201973.41M13.04M21.61%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

TBPH News

More News